The Sonicaid FM800 Encore - The fetal and maternal monitor
An exclusive advantage of this device is the unique CTG (cardiotocography) analysis included as standard, thus providing enhanced decision support.
The antepartum CTG analysis provides an objective, numerical, and consistent evaluation of the CTG, drawing on the largest collective experience database to support clinicians' visual assessment.
Furthermore, the intrapartum trend analysis measures changes in the FHR (fetal heart rate) over time, rapidly alerting clinicians to short-term variations, baseline rate, and deceleration size during the first stage of labor.
High-sensitivity transducers use advanced biocompatible materials to enable the most sensitive uterine activity monitoring possible for patients of all sizes.
The waterproof design facilitates thorough and complete cleaning, essential for infection control. The new "widebeam" ultrasound technology provides a wider, more uniform, and deeper beam shape, coupled with excellent digital Doppler sound, enabling clinicians to quickly locate and maintain contact with the fetal heart rate.
Improved FECG (fetal electrocardiography) performance in the most demanding environments allows for precise capture for quality decision-making, contributing to improved outcomes.
Additionally, improved performance in cases of low perfusion allows for printing and displaying the maternal heart rate as a trace for quick and easy differentiation from the fetal heart rate trace. The T840 telemetry system offers a wireless option for ambulatory monitoring of fetal heart rate and uterine activity during pregnancy and childbirth. It provides comfortable continuous monitoring with exceptional mobility, offering mothers unique flexibility in delivery positions.
The FM800 Encore incorporates new and unique technology to ensure accurate monitoring even in the most demanding circumstances, thereby reducing the need for direct fetal ECG monitoring. The "Location and Tracking" technology locks onto the fetal cardiac signal for optimal capture, while advanced fetal heart rate algorithms with artifact rejection ensure unparalleled FHR performance.